Covid-19 vaccine tested in Wuhan induces rapid immune response
What you need to know:
The study on 108 adults found that one dose of the vaccine known as recombinant adenovirus type-5 vectored Covid-19 vaccine (AD5), tested at three different levels on healthy adults aged between 18 and 60 years, appeared to induce a good immune response in some subjects.
With countries slowly reopening their economies by lifting lockdowns, the creation of an effective vaccine is seen as the long-term solution to controlling the Covid-19 pandemic
